The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Strayer David R since year 2005.
The trader's CIK number is 1270074.
At the time of this reporting, Strayer David R is the Chief Science/Medical Officer of Hemispherx Biopharma Inc .
(stock ticker symbol HEB).
See this page for all insider trading activities at Hemispherx Biopharma Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2017-05-02||HEB||Hemispherx Biopharma Inc||Buy||7,937||.63||5,000|
|2017-02-16||HEB||Hemispherx Biopharma Inc||Buy||9,892||.46||4,550|
|2012-05-17||HEB||Hemispherx Biopharma Inc||Buy||5,100||.26||1,300|
|2012-05-18||HEB||Hemispherx Biopharma Inc||Buy||44,900||.26||11,449|
|2010-06-22||HEB||Hemispherx Biopharma Inc||Sale||252||.56||141|
|2010-06-23||HEB||Hemispherx Biopharma Inc||Sale||50,648||.55||27,856|
|2010-06-16||HEB||Hemispherx Biopharma Inc||Buy||230,586||.57||132,586|
|2009-12-07||HEB||Hemispherx Biopharma Inc||Buy||12,000||.56||6,779|
|2008-09-25||HEB||Hemispherx Biopharma Inc||Buy||28,500||.35||9,975|
|2005-04-14||HEB||Hemispherx Biopharma Inc||Buy||2,000||1.39||2,780|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Strayer David R (Chief Science/Medical Officer of Hemispherx Biopharma Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.